FOLH1 and olivopontocerebellar atrophy: On the other hand, using PSMA PET-CT in some OPCa patients (as defined by conventional imaging) would screen out those with false-positive results, e.g., benign findings as bone hemangiomas, potentially shifting them to the cohort with clinically localized disease and enabling primary curative therapy.